Search

Mirati Therapeutics Inc

Abierto

SectorSanidad

0

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

-0.05% downside

Noticias sobre sentimiento de mercado

By Acuity

8%

92%

10 / 340 Clasificación en Healthcare

Mirati Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2026, 23:56 UTC

News

Starbucks Corp raised its full-year EPS guidance to approximately $2.60, reflecting strong U.S. same-store sales growth. Shares are gaining in after-market trading.

4 ago 2026, 23:56 UTC

News

Alphabet Inc's market valuation is approximately $4.6 trillion, bolstered by strong second-quarter results. Shares traded higher in after-market hours, reflecting positive sentiment.

4 ago 2026, 23:56 UTC

News

Ameresco Inc reported second-quarter revenue of $515.5 million, a 9% increase year-over-year. Shares are trading higher in after-market hours following the results.

4 ago 2026, 23:56 UTC

News

Advanced Energy Industries reported record Q2 revenue of $574.1 million, leading to shares trading higher in after-market hours.

4 ago 2026, 23:51 UTC

News

Cooper-Standard Holdings will present at the J.P. Morgan 2026 Auto Conference on August 12, with a focus on business strategies. Shares traded little changed after hours.

4 ago 2026, 23:51 UTC

News

Teradata Corp shares fell in after-market hours following mixed Q2 results and disappointing Q3 guidance, projecting adjusted EPS of $0.55 to $0.59.

4 ago 2026, 23:51 UTC

News

8x8 Inc. shares are lower in after-market hours following mixed first-quarter results, with revenue exceeding expectations but second-quarter EPS guidance falling short.

4 ago 2026, 23:51 UTC

News

Hyster-Yale Materials Handling shares fell in after-market trading following a second-quarter revenue of $812.9 million and a net loss of $31.6 million.

4 ago 2026, 23:51 UTC

Social Media
News

Arista Networks shares higher in after-market hours following strong second-quarter results, with adjusted EPS of $1.02 and optimistic third-quarter guidance.

4 ago 2026, 23:51 UTC

News
Social Media

Hecla Mining Co reported second-quarter EPS of $0.17 and revenue of $333.85 million, exceeding expectations. Shares are higher in after-market trading.

4 ago 2026, 23:51 UTC

Correlated Moves
ETF Constituents
News
Macro News

Vanguard Information Technology ETF is trading higher in after-market hours, supported by strong earnings from tech stocks and positive sentiment from UBS's coupon payments.

4 ago 2026, 23:46 UTC

News

Teladoc Health faces scrutiny amid revenue miss and lowered outlook. Shares traded roughly flat in after-market hours following the developments.

4 ago 2026, 23:42 UTC

News

Apple Inc. seeks a preliminary injunction against OpenAI amid a legal battle, as shares trade higher in after-market hours.

4 ago 2026, 23:41 UTC

News

Shutterstock shares are higher in after-market hours despite a $155.9 million net loss and a $173.7 million goodwill impairment charge reported for Q2.

4 ago 2026, 23:41 UTC

News

Compass Inc. shares rise in after-market hours following strong Q2 revenue of $4.306 billion and optimistic Q3 guidance of $3.85 billion to $4.05 billion.

4 ago 2026, 23:41 UTC

News
Social Media

Lumen Technologies reported second-quarter revenue of $2.805 billion, exceeding estimates. Shares rose after hours as the company reaffirmed its full-year guidance.

4 ago 2026, 23:41 UTC

News

Flywire Corp reported strong Q2 results, with revenue surpassing estimates. Shares are higher in after-market trading following the raised full-year guidance.

4 ago 2026, 23:41 UTC

News

Community Healthcare Trust shares declined in after-market hours following second-quarter results that missed earnings and revenue expectations. EPS was $0.06 versus an estimated $0.12.

4 ago 2026, 23:41 UTC

News

Bruker shares higher in after-market hours following Jefferies' price target increase to $62.00, maintaining a Buy rating amid broader performance challenges.

4 ago 2026, 23:41 UTC

Social Media
News

Alphabet Inc shares are higher in after-market trading following the expansion of its Gemini feature in Google Classroom for K-12 users.

4 ago 2026, 23:41 UTC

News
Social Media

Zeta Global Holdings reported Q2 revenue of $443 million but shares fell in after-market trading amid mixed reactions and concerns over growth guidance.

4 ago 2026, 23:41 UTC

Social Media
News

Palantir Technologies reported strong second-quarter results but shares fell during after-market hours, overshadowed by broader market gains and mixed sentiment.

4 ago 2026, 23:41 UTC

Social Media
News

Rocket Lab USA Inc secures a $397 million contract from the U.S. Space Force, driving shares higher in after-market trading.

4 ago 2026, 23:41 UTC

News

IDEXX Laboratories reported second-quarter revenue of $1.22 billion, a 9.7% increase year-over-year. Shares are trading higher in after-market hours following the results.

4 ago 2026, 23:41 UTC

Social Media
News

Kratos Defense and Security Solutions reported Q2 revenues of $458.8 million, exceeding estimates. Shares are advancing in after-market trading amid raised sales guidance.

4 ago 2026, 23:36 UTC

News

EOG Resources reported strong Q2 earnings of $5.15 per share and revenues of $8.62 billion, contributing to shares trading higher in after-market hours.

4 ago 2026, 23:36 UTC

News

Alphatec Holdings shares fell in after-market trading following a net loss of $26 million, despite meeting adjusted EPS expectations and exceeding revenue forecasts.

4 ago 2026, 23:36 UTC

News

Dell Technologies reported nearly 40% of revenue now from AI initiatives. Shares are lower in after-market trading following the announcement.

4 ago 2026, 23:36 UTC

News

Marathon Petroleum shares higher in after-market trading, reflecting stable performance and a market capitalization of approximately $91.74 billion.

4 ago 2026, 23:36 UTC

News

Western Union has launched the Stablecard for international transfers, but shares are trading lower in after-market hours following routine trading activity.

Comparación entre iguales

Cambio de precio

Mirati Therapeutics Inc previsión

Precio Objetivo

By TipRanks

-0.05% descenso

Estimación a 12 Meses

Media 58.67 USD  -0.05%

Máximo 59 USD

Mínimo 58 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Mirati Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

0

Comprar

5

Mantener

0

Vender

Sentimiento

By Acuity

10 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

EBITDA

Beneficio operativo

$

Acerca de Mirati Therapeutics Inc

Mirati Therapeutics, Inc. is a clinical-stage oncology company. It is focused on developing therapeutics to address the genetic and immunological promoters of cancer. Its clinical programs consist of product candidates, including Adagrasib (MRTX849), MRTX1133, and Sitravatinib. MRTX849 is an oral small-molecule therapy designed to shrink difficult-to-treat cancers harboring the KRAS G12C mutation. MRTX1133 is a small molecule-inhibitor of the KRASG12D mutation, designed to treat patients with unmet need. Sitravatinib is a spectrum-selective receptor tyrosine kinase (RTK) inhibitor that can stimulate the body’s immune response to fight cancer. MRTX849 is in Phase III and Phase I/II clinical trials and MRTX1133 is in preclinical development. Sitravatinib is in a Phase III clinical trial, and Phase I/II clinical trials. It also has additional preclinical discovery programs, which includes first-in-class and best-in-class product candidates designed to address mutations and tumors.
help-icon Live chat